Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Bossert

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Presse Medicale (Paris, France : 1983)|April 28, 2009
[Spondylarthropathy with Behçet's disease: response to infliximab]Eric Toussirot, Claire Schwartz, Chafika Hafsaoui, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|November 29, 2016
Imaging Guidance Improves the Results of Viscosupplementation with HANOX-M-XL in Patients with Ankle Osteoarthritis: Results of a Clinical Survey in 50 Patients Treated in Daily PracticeMarie Bossert, Daniel Boublil, Jean-Marc Parisaux, et al.
Joint Bone Spine|August 20, 2013
Hair-cycle changes in two patients taking tocilizumabClaire Vidon, Marie Bossert, Anne Lohse-Walliser, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|October 1, 2016
Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and MannitolThierry Conrozier, Ana-Maria Bozgan, Marie Bossert, et al.
Clinical and Experimental Rheumatology|November 30, 2020
Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional studyAnne Lohse, Marie Bossert, Ana-Maria Bozgan, et al.
Joint Bone Spine|March 21, 2026
Serum biomarkers fail to predict response to adalimumab in axial spondyloarthritis: results from discovery and validation cohortsAthan Baillet, Minh Vu Chuong Nguyen, Anaïs Courtier, et al.
Microbes and Infection|June 24, 2020
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, et al.
Rheumatology (Oxford, England)|December 29, 2020
Application of the OMERACT synovitis ultrasound scoring system in juvenile idiopathic arthritis: a multicenter reliability exerciseLinda Rossi-Semerano, Sylvain Breton, Luca Semerano, et al.
Clinical and Experimental Rheumatology|June 24, 2020
Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaborationThierry Conrozier, Anne Lohse, Jean-Charles Balblanc, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Presse Medicale (Paris, France : 1983)|April 28, 2009
[Spondylarthropathy with Behçet's disease: response to infliximab]Eric Toussirot, Claire Schwartz, Chafika Hafsaoui, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|November 29, 2016
Imaging Guidance Improves the Results of Viscosupplementation with HANOX-M-XL in Patients with Ankle Osteoarthritis: Results of a Clinical Survey in 50 Patients Treated in Daily PracticeMarie Bossert, Daniel Boublil, Jean-Marc Parisaux, et al.
Joint Bone Spine|August 20, 2013
Hair-cycle changes in two patients taking tocilizumabClaire Vidon, Marie Bossert, Anne Lohse-Walliser, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|October 1, 2016
Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and MannitolThierry Conrozier, Ana-Maria Bozgan, Marie Bossert, et al.
Clinical and Experimental Rheumatology|November 30, 2020
Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional studyAnne Lohse, Marie Bossert, Ana-Maria Bozgan, et al.
Joint Bone Spine|March 21, 2026
Serum biomarkers fail to predict response to adalimumab in axial spondyloarthritis: results from discovery and validation cohortsAthan Baillet, Minh Vu Chuong Nguyen, Anaïs Courtier, et al.
Microbes and Infection|June 24, 2020
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, et al.
Rheumatology (Oxford, England)|December 29, 2020
Application of the OMERACT synovitis ultrasound scoring system in juvenile idiopathic arthritis: a multicenter reliability exerciseLinda Rossi-Semerano, Sylvain Breton, Luca Semerano, et al.
Clinical and Experimental Rheumatology|June 24, 2020
Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaborationThierry Conrozier, Anne Lohse, Jean-Charles Balblanc, et al.
Pageof 2